JPMorgan Chase & Co’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$519K Sell
95,538
-168,877
-64% -$917K ﹤0.01% 4049
2025
Q1
$918K Buy
264,415
+228,268
+631% +$792K ﹤0.01% 3705
2024
Q4
$372K Buy
36,147
+22,735
+170% +$234K ﹤0.01% 4275
2024
Q3
$182K Sell
13,412
-28
-0.2% -$379 ﹤0.01% 4499
2024
Q2
$175K Sell
13,440
-428,701
-97% -$5.57M ﹤0.01% 4338
2024
Q1
$4.17M Sell
442,141
-572,134
-56% -$5.4M ﹤0.01% 2676
2023
Q4
$11.1M Buy
1,014,275
+1,001,315
+7,726% +$11M ﹤0.01% 2026
2023
Q3
$82.8K Sell
12,960
-2,564
-17% -$16.4K ﹤0.01% 4724
2023
Q2
$74.7K Buy
15,524
+258
+2% +$1.24K ﹤0.01% 4756
2023
Q1
$63K Sell
15,266
-3,612
-19% -$14.9K ﹤0.01% 4824
2022
Q4
$81K Buy
+18,878
New +$81K ﹤0.01% 4566